Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment
Prolactinomas (PRLomas) constitute approximately half of all pituitary adenomas and approximately one-fifth of them are diagnosed in males. The clinical presentation of PRLomas results from direct prolactin (PRL) action, duration and severity of hyperprolactinemia, and tumor mass effect. Male PRLoma...
Main Authors: | Lukasz Dzialach, Joanna Sobolewska, Zuzanna Zak, Wioleta Respondek, Przemysław Witek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1338345/full |
Similar Items
-
Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas
by: Oleksandr Voznyak, et al.
Published: (2024-02-01) -
Dopamine Agonists for Pituitary Adenomas
by: Odelia Cooper, et al.
Published: (2018-08-01) -
Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review
by: Congxin Dai, et al.
Published: (2021-10-01) -
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
by: Miriam da Costa OLIVEIRA, et al.
Published: (2020-01-01) -
Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience
by: Guadalupe Vargas-Ortega, et al.
Published: (2022-07-01)